Processa Pharmaceuticals, Inc. (PCSA) Stock Price History
Historical prices from 2014 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
PCSA Stock Price Trajectory (2014–2026)
As of March 1, 2026, Processa Pharmaceuticals, Inc. (PCSA) trades at $2.17, representing a +295.3% return over the past year. The stock has delivered a -61.7% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $717.50 on March 14, 2018. From this peak, PCSA has corrected -99.7%, currently trading 119% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers UTHR (+57.4% 1Y), ZLAB (-44.5% 1Y), and AMRN (+27.3% 1Y), PCSA has outperformed the peer group average. Compare PCSA vs UTHR →
Historical Price Data
Showing 30 of 3,014 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 2.23 | 2.25 | 2.10 | 2.17 | 2 | -2.69% |
| 2026-02-26 | 2.10 | 2.29 | 2.10 | 2.23 | 2 | +6.19% |
| 2026-02-25 | 1.99 | 2.15 | 1.93 | 2.10 | 2 | +8.25% |
| 2026-02-24 | 1.89 | 1.95 | 1.88 | 1.94 | 1 | +4.86% |
| 2026-02-23 | 2.06 | 2.09 | 1.80 | 1.85 | 1 | -11.90% |
| 2026-02-20 | 2.33 | 2.37 | 2.05 | 2.10 | 2 | -7.89% |
| 2026-02-19 | 2.27 | 2.40 | 2.21 | 2.28 | 20K | -1.30% |
| 2026-02-18 | 2.24 | 2.31 | 2.24 | 2.31 | 9K | +1.78% |
| 2026-02-17 | 2.22 | 2.27 | 2.19 | 2.27 | 1K | +2.24% |
| 2026-02-13 | 2.22 | 2.31 | 2.12 | 2.22 | 55K | -3.06% |
| 2026-02-12 | 2.56 | 2.56 | 2.25 | 2.29 | 54K | -6.53% |
| 2026-02-11 | 2.39 | 2.47 | 2.29 | 2.45 | 17K | +5.15% |
| 2026-02-10 | 2.30 | 2.44 | 2.22 | 2.33 | 30K | +3.10% |
| 2026-02-09 | 2.33 | 2.38 | 2.19 | 2.26 | 47K | -5.04% |
| 2026-02-06 | 2.14 | 2.45 | 2.10 | 2.38 | 58K | +9.68% |
| 2026-02-05 | 2.33 | 2.36 | 2.05 | 2.17 | 74K | -8.82% |
| 2026-02-04 | 2.41 | 2.42 | 2.27 | 2.38 | 64K | -2.46% |
| 2026-02-03 | 2.63 | 2.73 | 2.32 | 2.44 | 100K | -7.05% |
| 2026-02-02 | 2.92 | 3.05 | 2.42 | 2.63 | 174K | -12.50% |
| 2026-01-30 | 3.11 | 3.11 | 2.93 | 3.00 | 34K | -4.46% |
| 2026-01-29 | 3.19 | 3.19 | 3.09 | 3.14 | 24K | 0.00% |
| 2026-01-28 | 3.16 | 3.19 | 3.07 | 3.14 | 23K | -1.57% |
| 2026-01-27 | 3.12 | 3.19 | 3.10 | 3.19 | 22K | +1.92% |
| 2026-01-26 | 3.32 | 3.35 | 3.10 | 3.13 | 36K | -3.99% |
| 2026-01-24 | 3.48 | 3.48 | 3.01 | 3.26 | 89K | 0.00% |
| 2026-01-23 | 3.48 | 3.48 | 3.00 | 3.26 | 91K | +2.84% |
| 2026-01-22 | 3.15 | 3.30 | 3.13 | 3.17 | 55K | +1.28% |
| 2026-01-21 | 3.20 | 3.24 | 3.09 | 3.13 | 45K | -3.40% |
| 2026-01-20 | 3.45 | 3.48 | 3.18 | 3.24 | 122K | -8.47% |
| 2026-01-16 | 3.67 | 3.73 | 3.41 | 3.54 | 85K | -4.58% |
See PCSA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PCSA Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare PCSA vs AGIO
See how PCSA stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has PCSA stock performed recently?
PCSA returned +295.3% over the past year, beating its 5-year annualized CAGR of -61.7%. The stock trades above its 200-day moving average, confirming the uptrend.
What is PCSA's all-time high price?
Processa Pharmaceuticals, Inc. reached $717.50 on 2018-03-14. The 52-week high is $8.88. Current 1-year return of +295.3% places the stock closer to historical peaks.
Where can I download PCSA historical price data?
This page provides PCSA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.